Lutetium 177 Psma Therapy Germany
Hospitals of Germany the country-founder of the PSMA therapy offer high-quality medical services at affordable prices. PSMA-directed Radionuclide Therapy PSMA-PRRT PRLT incl Actinium-225 and Lutetium-177 Prostate cancer is the most common malignant tumor affecting men in Germany. Psma Targeted Radionuclide Therapy Of Metastatic Castration Resistant Prostate Cancer With 177lu Labeled Psma 617 Journal Of Nuclear Medicine Suppose your doctor thinks you have PC. Lutetium 177 psma therapy germany . 145 patients median age 73 years range 43-88 with mCRPC were treated with 177Lu-PSMA-617 in 12 therapy centres between February 2014 and July 2015 with one to four therapy. Establishment of the current position of 177 Lu-PSMA-RLT in mCRPC in 2017. Neuroendocrine Tumors NETs Treatment with Lutetium 177-PSMA in Germany Direct prices from the best hospitals in Germany We will help you save money for NETs treatment in Germany Patient support 247. What is Lutetium 177 PSMA Therapy Prostat